AbbVie (NYSE:ABBV) Lifted to “Buy” at The Goldman Sachs Group
The Goldman Sachs Group upgraded shares of AbbVie (NYSE:ABBV – Free Report) from a neutral rating to a buy rating in a report published on Monday, Marketbeat reports. The firm currently has $173.00 price target on the stock. Other analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft began coverage on […]
More Stories
Choreo LLC Trims Stake in iShares California Muni Bond ETF (NYSEARCA:CMF)
Choreo LLC cut its position in iShares California Muni Bond ETF (NYSEARCA:CMF – Free Report) by 3.1% in the second...
Choreo LLC Acquires 7,366 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)
Choreo LLC boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 229.9% during the...
Wedbush Securities Inc. Cuts Stock Holdings in Colgate-Palmolive (NYSE:CL)
Wedbush Securities Inc. trimmed its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 18.8% in the second quarter,...
Clifford Swan Investment Counsel LLC Lowers Position in L3Harris Technologies, Inc. (NYSE:LHX)
Clifford Swan Investment Counsel LLC lowered its stake in shares of L3Harris Technologies, Inc. (NYSE:LHX – Free Report) by 5.3%...
Wedbush Securities Inc. Trims Stock Holdings in Vanguard S&P 500 Growth ETF (NYSEARCA:VOOG)
Wedbush Securities Inc. lowered its holdings in shares of Vanguard S&P 500 Growth ETF (NYSEARCA:VOOG – Free Report) by 8.3%...
3M (NYSE:MMM) Shares Acquired by Choreo LLC
Choreo LLC boosted its holdings in shares of 3M (NYSE:MMM – Free Report) by 23.9% in the second quarter, according...